Nepentes Buy Continues Sanofi's Consumer Product Shopping Spree
This article was originally published in The Rose Sheet
Executive Summary
Sanofi-Aventis further expands its consumer product business with a $130.4 million offer for Polish drug, dietary supplement and cosmetics firm Nepentes Group
You may also be interested in...
With $1.9 Bil. Bid For Chattem, Sanofi Knocks On Door To U.S. OTC Market
With its $1.9 billion bid for personal-care and over-the-counter drug manufacturer Chattem, French pharmaceutical giant Sanofi-Aventis stands to gain a toehold in the sizeable U.S. consumer health sector and beef up its presence in emerging markets
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program